Skip to content

Clinical trials

Completed Overweight trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Status: Completed Country / region: China Clear all

131 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20112
20122
20143
20161
20172
20183
20194
20207
20219
202210
202323
202434
202524
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed131

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S8
Vincentage Pharma Co., Ltd7
Eli Lilly and Company6
Fujian Shengdi Pharmaceutical Co., Ltd.6
Shanghai Minwei Biotechnology Co., Ltd6
BrightGene Bio-Medical Technology Co., Ltd.5
Chendu DIAO Pharmaceutical Group CO., LTD.4
Gan and Lee Pharmaceuticals, USA4
Shandong Suncadia Medicine Co., Ltd.4
Beijing QL Biopharmaceutical Co.,Ltd3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight131
Obesity117
Diabetes Mellitus, Type 215
Metabolic Syndrome5
Polycystic Ovary Syndrome5
Weight Loss4
Diabetes, Gestational3
Diabetes Mellitus2
Intellectual Disability2
Nutrition Disorders2

Trials

Showing 1 to 25 of 131. Each trial links to its page on Pharma Observatory.

31 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.